| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/01/2012 | CN1951899B 阿司匹林触发的脂质介体 Aspirin-triggered lipid mediators |
| 02/01/2012 | CN1879761B 一种调节机体免疫力、抗突变保健品及其生产方法 A regulator of immunity, anti-mutagenic health products and production methods |
| 02/01/2012 | CN102341411A Anti-lymphotoxin antibodies |
| 02/01/2012 | CN102341407A Modified omci as complement inhibitor |
| 02/01/2012 | CN102341386A Pyridine derivative |
| 02/01/2012 | CN102341385A Piperazine compound capable of inhibiting prostaglandin d synthase |
| 02/01/2012 | CN102341372A Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 02/01/2012 | CN102341121A Anti-rhesus d monoclonal antibody |
| 02/01/2012 | CN102341114A Plant extract compositions for prevention and treatment of influenza |
| 02/01/2012 | CN102341106A Compounds and methods for inhibiting mmp2 and mmp9 |
| 02/01/2012 | CN102337273A Portunus trituberculatus anti-lipopolysaccharide factor PtALF-5 gene and encoding proteins and application thereof |
| 02/01/2012 | CN102337272A Portunus trituberculatus anti-lipopolysaccharide factor PtALF-3 gene and encoding proteins and application thereof |
| 02/01/2012 | CN102337271A Portunus trituberculatus anti-lipopolysaccharide factor PtALF-2 gene and encoding proteins and application thereof |
| 02/01/2012 | CN102336739A Loratadine compound and preparation method thereof |
| 02/01/2012 | CN102336720A 2-aminothiazole derivatives, and preparation method and application thereof |
| 02/01/2012 | CN102336716A 嘧啶衍生物 Pyrimidine derivatives |
| 02/01/2012 | CN102335417A Health-care product for restoring physical strength in later period of cold |
| 02/01/2012 | CN102335413A Preparation method, product and application of lactobacillus whole peptidoglycan with effect for resisting beta-lactoglobulin hypersusceptibility |
| 02/01/2012 | CN102335347A Panax pseudo-ginseng and panax quinquefolium soft capsules |
| 02/01/2012 | CN102335336A Traditional Chinese medicine for treating lupus sebaceus |
| 02/01/2012 | CN102335285A Chinese medicinal preparation for resisting fatigue, and preparation method thereof |
| 02/01/2012 | CN102335274A Chinese medicinal composition for preventing and treating inflammation-related diseases |
| 02/01/2012 | CN102335271A Preparation method and quality control method of heartleaf houttuynia herb injection |
| 02/01/2012 | CN102335224A Method for cellulase and ultrasonic wave assisted extraction of flavonoids in peanut hull |
| 02/01/2012 | CN102335220A Anticancer and immunological enhancement lepidium long sea cucumber preparation |
| 02/01/2012 | CN102335217A Promoter for generation of glutathione |
| 02/01/2012 | CN102335212A Chinese medicine Jinshuibao golden pill preparation and preparation method thereof |
| 02/01/2012 | CN102335206A Mythic Fungus wall-broken spore powder capsule |
| 02/01/2012 | CN102335205A Chinese medicinal composition, medicinal preparation and preparation method thereof |
| 02/01/2012 | CN102335184A Application of 5,6,7,4'-tetrahydroxyflavone and derivatives thereof as JAK tyrosine protein kinase inhibitor |
| 02/01/2012 | CN102335173A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 02/01/2012 | CN102335131A Osthole micro emulsion, osthole micro emulsion sustained-release patch and preparation method thereof |
| 02/01/2012 | CN102100875B 一种微波辅助超临界提取姜黄有效成分的工艺方法 A microwave-assisted process for supercritical extraction of active ingredients turmeric |
| 02/01/2012 | CN102008705B 一种用于感冒早期的药食两用姜枣营卫颗粒 Edible ginger Zaoying Methodist particles for the early cold |
| 02/01/2012 | CN101926771B 一种酰化支链淀粉修饰卡介菌多糖核酸口服兽用脂质体及其冻干制剂 Acylation modified amylopectin PSN card veterinary oral and lyophilized preparation of liposomes |
| 02/01/2012 | CN101816689B 人参的处理方法 Treatment of ginseng |
| 02/01/2012 | CN101810657B 含有西洋参的组合物和西洋参茶饮料 Compositions containing ginseng and ginseng tea |
| 02/01/2012 | CN101804155B 一种用于肿瘤放、化疗以及术后体虚引起的气血两虚症药物及其制备方法 A tumor radiotherapy and chemotherapy as well as physically weak after blood deficiency syndrome caused by two drugs and their preparation methods |
| 02/01/2012 | CN101775360B 一种地衣芽胞杆菌及原药的制备方法 Preparation method of Bacillus licheniformis and the original drug |
| 02/01/2012 | CN101745024B 一种龙脑苷在控制参麦注射液质量时的用途 A Long cerebrosides in quality control purposes shenmai injection |
| 02/01/2012 | CN101612253B 一种用于治疗丘疹样荨麻疹的药物组合物 A pharmaceutical composition for the treatment of papular urticaria |
| 02/01/2012 | CN101554197B 功能性多糖茶及其制备方法 Functional Multi-Ribes and its preparation method |
| 02/01/2012 | CN101511827B 作为免疫调制剂的吡啶-4-基衍生物 As immunomodulating agents pyridin-4-yl derivative |
| 02/01/2012 | CN101491334B 一种具有增强免疫力功能的保健食品 Strengthening the immune system function having a health food |
| 02/01/2012 | CN101390868B 一种植物多糖及其制备方法和用途 A plant polysaccharides and their preparation and use |
| 02/01/2012 | CN101358225B 高唾液酸含量的免疫球蛋白抗体的制备方法与应用 Preparation of high sialic acid content and application of immunoglobulin antibody |
| 02/01/2012 | CN101347408B 青藤碱静脉输液制剂 Sinomenine intravenous infusion formulations |
| 02/01/2012 | CN101152318B 一种用于调神、调心、调胃和调肠的中药 A Tiaoshen, aligning, adjusting the stomach and intestines tune medicine |
| 02/01/2012 | CN101124213B 磺酰氨基环状衍生物及其应用 Sulphonamido cyclic derivatives and its application |
| 01/31/2012 | US8106218 Pharmaceutical compounds |
| 01/31/2012 | US8106214 2-imino-4-(thio) oxo-5-polycyclovinylazolines for use as PI3 kinase inhibitors |
| 01/31/2012 | US8106153 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 01/31/2012 | US8106097 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 01/31/2012 | US8106063 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 01/31/2012 | US8106015 Method for enhancing immune response with peptide |
| 01/31/2012 | US8105608 Method of treatment using ligand-immunogen conjugates |
| 01/31/2012 | US8105605 Allergen formulation |
| 01/31/2012 | US8105599 Administering a compound which binds to a C-type lectin on the surface of a dendritic cell, with the proviso that the C-type lectin is not the DEC-205 receptor |
| 01/31/2012 | US8105580 Methods of using adipose derived stem cells to promote wound healing |
| 01/31/2012 | US8105574 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 01/31/2012 | CA2463989C Pyrimidine derivatives, pharmaceutical compositions containing these compounds, the use thereof and process for the preparation thereof |
| 01/31/2012 | CA2426490C Vaccine composition comprising an antigen and a peptide having adjuvant properties |
| 01/31/2012 | CA2393682C Depsipeptide and congeners thereof for use as immunosuppressants |
| 01/31/2012 | CA2208790C Adjuvant for vaccines comprising a hydrophobic sulfolipid polysaccharide |
| 01/26/2012 | WO2012012667A2 Methods and compositions for modification of a hla locus |
| 01/26/2012 | WO2012012531A2 Compositions and methods featuring il-6 and il-21 antagonists |
| 01/26/2012 | WO2012012477A1 Substituted 3-phenyl-1,2,4-oxadiazole compounds |
| 01/26/2012 | WO2012012390A1 Botanical composition and methods of manufacture and use |
| 01/26/2012 | WO2012011992A2 Ricin vaccine and methods of making and using thereof |
| 01/26/2012 | WO2012011917A1 Administration of rifalazil to immunocompromised patients |
| 01/26/2012 | WO2012011836A1 The new stable polyethylene glycol conjugate of interferon alpha, represented by one positional isomer |
| 01/26/2012 | WO2012011619A1 Method for separating ephedrine from ephedra sinica stapf at a high yield, and adjuvant for enhancing immunity containing ephedrine as an active ingredient |
| 01/26/2012 | WO2012011591A1 Fused heterocyclic compound and application thereof |
| 01/26/2012 | WO2012011192A1 Tacrolimus-containing oil-in-water type creamy composition |
| 01/26/2012 | WO2012011113A2 Regulatory immune cells with enhanced targeted cell death effect |
| 01/26/2012 | WO2012009977A1 FULLY HUMAN TNFα-FAB ANTIBODY AND PEGYLATED ANTIBODY THEREOF |
| 01/26/2012 | WO2012009790A1 Cross-protective pathogen protection, methods and compositions thereof |
| 01/26/2012 | WO2011150457A3 Haematopoietic-prostaglandin d2 synthase inhibitors |
| 01/26/2012 | WO2011143280A3 Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling |
| 01/26/2012 | WO2011115458A3 Dual antagonist for tnf-α and il-21 for preventing and treating autoimmune diseases |
| 01/26/2012 | WO2011115456A3 Tnf-α and tweak dual antagonist for the prophylaxis and treatment of autoimmune diseases |
| 01/26/2012 | WO2011100295A3 Alpha-methyl-tryptophan as an inhibitor of indoleamine dioxygenase |
| 01/26/2012 | WO2011097527A3 Immunoprotection of therapeutic moieties using enhanced fc regions |
| 01/26/2012 | WO2010144140A8 Egfr and par2 regulation of intestinal permeability |
| 01/26/2012 | US20120022236 Recombinant Anti-VLA4 Antibody Molecules |
| 01/26/2012 | US20120022154 N-hydroxy c29-amide derivatives of oleandrane |
| 01/26/2012 | US20120022138 Means for inhibiting the expression of ang2 |
| 01/26/2012 | US20120022130 METHOD OF REGULATING NFATc2 ACTIVITY IN LYMPHOCYTES |
| 01/26/2012 | US20120022119 Heterocyclic antagonists of prostaglandin d2 receptors |
| 01/26/2012 | US20120022113 Methods for suppressing tipdc trafficking or accumulation and preventing hypercytokinemia |
| 01/26/2012 | US20120022109 Oxadiazole derivatives |
| 01/26/2012 | US20120022094 Pharmaceutical formulations |
| 01/26/2012 | US20120022092 Protein kinase c inhibitors and uses thereof |
| 01/26/2012 | US20120022081 Method of using diketopiperazines and composition containing them |
| 01/26/2012 | US20120022076 Derivatives of n-(arylamino)sulfonamides as inhibitors of mek |
| 01/26/2012 | US20120022068 NOVEL HETEROCYCLIC NF-kB INHIBITORS |
| 01/26/2012 | US20120022064 Dihydroquinolinone derivatives |
| 01/26/2012 | US20120022048 Anti-proliferative substituted pyrazolo[3,4-d]pyrimidines derivatives (SPP) to inhibit immune activation, virus replication and tumor growth |
| 01/26/2012 | US20120022043 Pyrazolopyrimidine jak inhibitor compounds and methods |
| 01/26/2012 | US20120022041 Substituted heterocyclic compounds |